Wraps Up Successful Participation at CPHI Milan 2026

Wraps Up Successful Participation at CPHI Milan 2026

Milan, Italy – October 6-8, 2026

CPHI Milan 2026, one of the world’s most influential pharma ingredient exhibitions, has successfully concluded at Fiera Milano, Italy. BioGin Pharmaceutical Co., Ltd presented our portfolio of botanical extracts and pharmaceutical raw materials at Booth No. 3C114, connecting face-to-face with existing and prospective partners from Europe, North America, the Middle East, Southeast Asia and beyond.

Hosted from October 6 to 8, the event gathered key players across the whole pharmaceutical supply chain, covering hot topics including supply chain resilience, regulatory compliance, sustainable manufacturing and application of natural bioactive ingredients.

At our booth, we showcased flagship products including PS, α-GPC, PEA, OEA, Saffron Extract, Drinking Granule series and Softgel series, and etc. Our team displayed full quality control systems and global compliance documentation such as FDA, GRAS and ISO certifications.

Our sales and technical teams held one-on-one discussions with visitors on manufacturing process, specifications, documentation packages, lead time and custom development services. We collected valuable market feedback and secured multiple letters of intent for future cooperation.

This exhibition strengthened partnerships with our global clients and expanded our market footprint across Europe and other overseas regions, further elevating our brand recognition within botanical extracts and pharma raw material sectors.

Moving forward, BioGin Pharmaceutical Co., Ltd will keep investing in R&D and strict international quality & compliance management. We will continue to deliver premium raw materials and reliable supply chain solutions for global partners, jointly building a stable and sustainable pharmaceutical & health ingredient supply chain.

We appreciate all visitors who stopped by our booth. Looking forward to meeting you again.